Literature DB >> 16616353

Coping strategies and interpersonal support in patients with irritable bowel syndrome and inflammatory bowel disease.

Michael P Jones1, Sarah Wessinger, Michael D Crowell.   

Abstract

BACKGROUND & AIMS: Coping strategies are used to manage conflict and illness and can have adaptive or maladaptive effects on health status. Perceived availability and quality of social support also influences health status. Coping strategies and social support have not been well studied in irritable bowel syndrome (IBS) or inflammatory bowel disease (IBD). To understand their role better, coping strategies, social support, and psychiatric distress were assessed in patients with IBS and IBD and in controls.
METHODS: Participants completed the Ways of Coping Questionnaire, the Interpersonal Support Evaluation, Symptom Checklist-90-revised, IBS-Quality of Life (QOL), and IBD-QOL. Participants also completed the Toronto Alexithymia Scale and Somatosensory Amplification Scale.
RESULTS: The study population included 55 controls, 74 IBS patients, and 48 IBD patients. The IBS and IBD patients had higher scores on measures of psychiatric distress, alexithymia, and somatosensory amplification than controls, but did not differ from one another. QOL scores did not differ between patients with IBS and IBD. Patients with IBS and IBD reported significantly less interpersonal support than controls. Controls identified planful problem solving as the dominant coping strategy whereas patients with IBS and IBD relied significantly less on planful problem solving and positive reappraisal and more on escape-avoidance strategies.
CONCLUSIONS: Compared with controls, IBS and IBD patients had increased levels of psychiatric distress, a poorer QOL, less interpersonal support, and greater reliance on passive coping strategies. These data suggest that psychosocial disturbances are common in IBD and IBS and suggest that the observed differences reflect illness behavior rather than a disorder-specific process.

Entities:  

Mesh:

Year:  2006        PMID: 16616353     DOI: 10.1016/j.cgh.2005.12.012

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  47 in total

Review 1.  Pain and inflammatory bowel disease.

Authors:  Klaus Bielefeldt; Brian Davis; David G Binion
Journal:  Inflamm Bowel Dis       Date:  2009-05       Impact factor: 5.325

2.  A comparison of self-perceived health status in inflammatory bowel disease and irritable bowel syndrome patients from a Canadian national population survey.

Authors:  Linda Y L Tang; Alice Nabalamba; Leslie A Graff; Charles N Bernstein
Journal:  Can J Gastroenterol       Date:  2008-05       Impact factor: 3.522

3.  Optimizing management of Crohn's disease within a project management framework: results of a pilot study.

Authors:  Laurie Keefer; Bethany Doerfler; Caroline Artz
Journal:  Inflamm Bowel Dis       Date:  2011-02-23       Impact factor: 5.325

4.  Role of Coping With Symptoms in Depression and Disability: Comparison Between Inflammatory Bowel Disease and Abdominal Pain.

Authors:  Miranda A L van Tilburg; Robyn L Claar; Joan M Romano; Shelby L Langer; Lynn S Walker; William E Whitehead; Bisher Abdullah; Dennis L Christie; Rona L Levy
Journal:  J Pediatr Gastroenterol Nutr       Date:  2015-10       Impact factor: 2.839

Review 5.  Psychiatric comorbidity in the treatment of patients with inflammatory bowel disease.

Authors:  Branislav R Filipovic; Branka F Filipovic
Journal:  World J Gastroenterol       Date:  2014-04-07       Impact factor: 5.742

6.  Pediatric Pain Beliefs Questionnaire: Psychometric Properties of the Short Form.

Authors:  Amanda L Stone; Lynn S Walker; Kelsey T Laird; Kezia C Shirkey; Craig A Smith
Journal:  J Pain       Date:  2016-06-27       Impact factor: 5.820

7.  Oral treatment with genistein reduces the expression of molecular and biochemical markers of inflammation in a rat model of chronic TNBS-induced colitis.

Authors:  Jan Seibel; Almut F Molzberger; Torsten Hertrampf; Ute Laudenbach-Leschowski; Patrick Diel
Journal:  Eur J Nutr       Date:  2009-02-21       Impact factor: 5.614

8.  Mechanisms of Quality of Life and Social Support in Inflammatory Bowel Disease.

Authors:  Laura Katz; Dean A Tripp; Mark Ropeleski; William Depew; J Curtis Nickel; Stephen Vanner; Michael J Beyak
Journal:  J Clin Psychol Med Settings       Date:  2016-03

9.  Impact of perceived stigma on inflammatory bowel disease patient outcomes.

Authors:  Tiffany H Taft; Laurie Keefer; Christoph Leonhard; Michele Nealon-Woods
Journal:  Inflamm Bowel Dis       Date:  2009-08       Impact factor: 5.325

10.  Prototype evaluation of a self-management Internet diary for patients with ulcerative colitis.

Authors:  Lucia Snoei; Ad van Bodegraven; Bas Oldenburg; Theo Stijnen; Ad A Kaptein
Journal:  Patient Prefer Adherence       Date:  2009-11-03       Impact factor: 2.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.